Evan Loh, CEO at Paratek Pharmaceuticals, Inc. (PRTK), sold 8,805 shares at $3.47 ($31K) on 2022-10-28, disclosed to the SEC on 2022-11-01.
Scheduled sale ($31k) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PRTK | SELL | 2022-12-14 | $393K | — | Filing → |
| PRTK | SELL | 2022-08-10 | $237K | — | Filing → |
| PRTK | SELL | 2021-12-15 | $753K | — | Filing → |